In cancer, integrins are often dysregulated, contributing to several hallmarks of cancer, including uncontrolled cell proliferation, resistance to apoptosis, and enhanced metastatic potential. The altered expression and function of integrins can disrupt normal cell-ECM interactions and activate various intracellular signaling pathways that promote tumor progression and metastasis.
